# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-281557
Filing Date
2025-11-14
Accepted
2025-11-14 07:30:52
Documents
92
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | itrm-20250930.htm iXBRL | 10-Q | 3293080
2 | EX-10.1 | itrm-ex10_1.htm | EX-10.1 | 327983
3 | EX-31.1 | itrm-ex31_1.htm | EX-31.1 | 18483
4 | EX-31.2 | itrm-ex31_2.htm | EX-31.2 | 18743
5 | EX-32.1 | itrm-ex32_1.htm | EX-32.1 | 11244
6 | EX-32.2 | itrm-ex32_2.htm | EX-32.2 | 11236
| Complete submission text file | 0001193125-25-281557.txt |  | 13225934

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | itrm-20250930.xsd | EX-101.SCH | 1942262
95 | EXTRACTED XBRL INSTANCE DOCUMENT | itrm-20250930_htm.xml | XML | 2112496

Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 251481214
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)